A citation-based method for searching scientific literature

Seoung-Ae Lee, Bo-Ram Kim, Bu-Kyung Kim, Dong-Won Kim, Won-Jun Shon, Na-Rae Lee, Kyung-Soo Inn, Bum-Joon Kim. Biomaterials 2013
Times Cited: 25







List of co-cited articles
68 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Paal F Brunsvig, Steinar Aamdal, Marianne K Gjertsen, Gunnar Kvalheim, Carrie J Markowski-Grimsrud, Ingunn Sve, Marianne Dyrhaug, Sissel Trachsel, Mona Møller, Jon A Eriksen,[...]. Cancer Immunol Immunother 2006
161
48

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study.
S L Bernhardt, M K Gjertsen, S Trachsel, M Møller, J A Eriksen, M Meo, T Buanes, G Gaudernack. Br J Cancer 2006
191
40

Cancer vaccination with telomerase peptide GV1001.
Jon Amund Kyte. Expert Opin Investig Drugs 2009
61
40


Tumor-suppressive effect of a telomerase-derived peptide by inhibiting hypoxia-induced HIF-1α-VEGF signaling axis.
Bu-Kyung Kim, Bo-Ram Kim, Hyun-Joo Lee, Seoung-Ae Lee, Byoung-Jun Kim, Hong Kim, Yu-Sub Won, Won-Jun Shon, Na-Rae Lee, Kyung-Soo Inn,[...]. Biomaterials 2014
16
56

Novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase.
Hyun-Hee Park, Kyu-Yong Lee, Sangjae Kim, Jessica Woojin Lee, Na-Young Choi, Eun-Hye Lee, Young Joo Lee, Sang-Hun Lee, Seong-Ho Koh. Neurobiol Aging 2014
31
36

Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.
Paal Fr Brunsvig, Jon Amund Kyte, Christian Kersten, Stein Sundstrøm, Mona Møller, Marta Nyakas, Gaute L Hansen, Gustav Gaudernack, Steinar Aamdal. Clin Cancer Res 2011
110
28

Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer.
V E Shaw, D J Naisbitt, E Costello, W Greenhalf, B K Park, J P Neoptolemos, G W Middleton. Expert Rev Vaccines 2010
32
28

Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.
Caroline Staff, Fariba Mozaffari, Jan-Erik Frödin, Håkan Mellstedt, Maria Liljefors. Int J Oncol 2014
35
28

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma.
Tim F Greten, Alejandro Forner, Firouzeh Korangy, Gisele N'Kontchou, Nathalie Barget, Carmen Ayuso, Lars A Ormandy, Michael P Manns, Michel Beaugrand, Jordi Bruix. BMC Cancer 2010
130
24


Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients.
Jon Amund Kyte, Gustav Gaudernack, Svein Dueland, Sissel Trachsel, Lars Julsrud, Steinar Aamdal. Clin Cancer Res 2011
73
20

Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001.
Else-Marit Inderberg-Suso, Sissel Trachsel, Kari Lislerud, Anne-Marie Rasmussen, Gustav Gaudernack. Oncoimmunology 2012
64
20

A telomerase-derived peptide regulates reactive oxygen species and hepatitis C virus RNA replication in HCV-infected cells via heat shock protein 90.
Seoung-Ae Lee, Jinhee Kim, Jihyun Sim, Sang-Gyune Kim, Yoon-Hoh Kook, Chung-Gyu Park, Hang-Rae Kim, Bum-Joon Kim. Biochem Biophys Res Commun 2016
10
50

The Anti-inflammatory Effect of GV1001 Mediated by the Downregulation of ENO1-induced Pro-inflammatory Cytokine Production.
Jiyea Choi, Hyemin Kim, Yejin Kim, Mirim Jang, Jane Jeon, Young-Il Hwang, Won Jun Shon, Yeong Wook Song, Jae Seung Kang, Wang Jae Lee. Immune Netw 2015
23
21



Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Gary Middleton, Paul Silcocks, Trevor Cox, Juan Valle, Jonathan Wadsley, David Propper, Fareeda Coxon, Paul Ross, Srinivasan Madhusudan, Tom Roques,[...]. Lancet Oncol 2014
187
16

Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner.
Hong Kim, Myung-Soo Choi, Kyung-Soo Inn, Bum-Joon Kim. Sci Rep 2016
24
16

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides.
Robert E Hunger, Kristin Kernland Lang, Carrie J Markowski, Sissel Trachsel, Mona Møller, Jon A Eriksen, Anne-Marie Rasmussen, Lasse R Braathen, Gustav Gaudernack. Cancer Immunol Immunother 2011
32
12

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer.
Nicola E Annels, Victoria E Shaw, Rachel F Gabitass, Lucinda Billingham, Pippa Corrie, Martin Eatock, Juan Valle, David Smith, Jonathan Wadsley, David Cunningham,[...]. Cancer Immunol Immunother 2014
63
12

Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells.
N Uchida, T Otsuka, H Shigematsu, M Maeda, Y Sugio, Y Itoh, Y Niho. Leuk Res 1999
21
9

Sick chaperones, cellular stress, and disease.
Alberto J L Macario, Everly Conway de Macario. N Engl J Med 2005
239
8



Peptide-mediated protein delivery-which pathways are penetrable?
Helin Räägel, Pille Säälik, Margus Pooga. Biochim Biophys Acta 2010
63
8

Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus.
Yu-Ping Wang, Fei Liu, Hong-Wei He, Yan-Xin Han, Zong-Gen Peng, Bao-Wei Li, Xue-Fu You, Dan-Qing Song, Zhuo-Rong Li, Li-Yan Yu,[...]. Antimicrob Agents Chemother 2010
46
8

A role for molecular chaperone Hsc70 in reovirus outer capsid disassembly.
Tijana Ivanovic, Melina A Agosto, Kartik Chandran, Max L Nibert. J Biol Chem 2007
41
8



The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
Jing Li, Joanna Soroka, Johannes Buchner. Biochim Biophys Acta 2012
308
8

The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer.
Michael W Hance, Krystal D Nolan, Jennifer S Isaacs. Cancers (Basel) 2014
28
8


Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally.
Wei Li, Fred Tsen, Divya Sahu, Ayesha Bhatia, Mei Chen, Gabriele Multhoff, David T Woodley. Int Rev Cell Mol Biol 2013
41
8

Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
Roland Schroers, Xue F Huang, Juergen Hammer, Jingwu Zhang, Si-Yi Chen. Cancer Res 2002
80
8

GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers.
Pilar Nava-Parada, Leisha A Emens. Curr Opin Mol Ther 2007
19
10

RNAi-mediated gene silencing in non-human primates.
Tracy S Zimmermann, Amy C H Lee, Akin Akinc, Birgit Bramlage, David Bumcrot, Matthew N Fedoruk, Jens Harborth, James A Heyes, Lloyd B Jeffs, Matthias John,[...]. Nature 2006
977
8


Apoptosis of guinea pig cochlear hair cells following chronic aminoglycoside treatment.
T Nakagawa, H Yamane, M Takayama, K Sunami, Y Nakai. Eur Arch Otorhinolaryngol 1998
58
8

Therapeutics of hearing loss: expectations vs reality.
Orna Atar, Karen B Avraham. Drug Discov Today 2005
24
8

Ototoxicity: therapeutic opportunities.
Leonard P Rybak, Craig A Whitworth. Drug Discov Today 2005
177
8


A systemic gentamicin pathway across the stria vascularis.
Chun Fu Dai, Peter S Steyger. Hear Res 2008
46
8


Protective effect of telomerase-based 16-mer peptide vaccine (GV1001) on inferior epigastric island skin flap survivability in ischaemia-reperfusion injury rat model.
Yung Ki Lee, Beta Subakti Nata'atmaja, Byung Hwi Kim, Chang Sik Pak, Chan Yeong Heo. J Plast Surg Hand Surg 2017
11
18


Auditory brainstem responses to clicks and tone bursts in C57 BL/6J mice.
P Scimemi, R Santarelli, A Selmo, F Mammano. Acta Otorhinolaryngol Ital 2014
19
10

Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo.
C F Dai, D Mangiardi, D A Cotanche, P S Steyger. Hear Res 2006
71
8


D-methionine (D-met) significantly reduces kanamycin-induced ototoxicity in pigmented guinea pigs.
Kathleen C M Campbell, Seth M Martin, Robert P Meech, Tim L Hargrove, Steven J Verhulst, Daniel J Fox. Int J Audiol 2016
20
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.